SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease.
Document Type
Article
Publication Date
6-1-2019
Publication Title
Lancet Diabetes Endocrinol
Clinical Institute
Kidney & Diabetes
Department
Nephrology
Department
Endocrinology
Recommended Citation
Tuttle, Katherine, "SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease." (2019). Articles, Abstracts, and Reports. 1476.
https://digitalcommons.providence.org/publications/1476
COinS
